Mesa Biotech, Inc.

Manufacturers of COVID-19 tests that reached the market via the emergency use authorization (EUA) process will need to collect additional information to help mitigate risks posed by viral mutations, t

Medical Device Acquisitions The first quarter featured 24 device M&A transactions, 17 of which had disclosed values that together totaled $10.2bn, versus the fourth quarter of 2020, when 21 deals tota

Medical device companies are increasingly looking at digital health and diagnostics solutions to bolster their portfolios. This week, Thermo Fisher Scientific announced plans to acquire molecular di